Business

BTX 1503 End of Phase 2 Milestone with FDA

BTX 1503 End of Phase 2 Milestone with FDA

articleBotanix Pharmaceuticals LimitedJuly 16, 20203/company/botanix-pharmaceuticals-ltd/news/btx-1503-end-of-phase-2-milestone-with-fda
BTX 1503 End of Phase 2 Milestone with FDA

About this update from Botanix Pharmaceuticals Limited

[{"type":"text","content":"Botanix Pharmaceuticals Ltd has released a press release. View Attachment","length":241,"tagName":"div"}]

More updates from Botanix Pharmaceuticals Limited